These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 7912764)

  • 21. Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells.
    Rao AS; Fontes P; Zeevi A; Trucco M; Dodson FS; Rybka WB; Shapiro R; Jordan M; Pham SM; Rilo HL
    Transplant Proc; 1995 Feb; 27(1):210-2. PubMed ID: 7878975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixed xenogeneic chimerism and tolerance III. A nonlethal approach to induce donor-specific transplantation tolerance to simultaneous islet xenografts.
    Li H; Abou el-Ezz AY; Gambrell BE; Ildstad ST
    Transplantation; 1995 Jul; 60(1):59-65. PubMed ID: 7624944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
    J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras.
    Chan WF; Razavy H; Luo B; Shapiro AM; Anderson CC
    J Immunol; 2008 Apr; 180(8):5177-86. PubMed ID: 18390699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
    Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
    J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up.
    Rao AS; Fontes P; Iyengar A; Shapiro R; Dodson F; Corry R; Pham S; Jordan M; Zeevi A; Rastellini C; Aitouche A; Egidi F; Gritsch HA; Reyes J; Fung JJ; Starzl TE
    Transplant Proc; 1997; 29(1-2):1184-5. PubMed ID: 9123264
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of bone marrow transplantation on survival of allogeneic pancreatic islets with short-term tacrolimus conditioning in rats.
    Girman P; Kríz J; Dovolilová E; Cíhalová E; Saudek F
    Ann Transplant; 2001; 6(2):43-5. PubMed ID: 11803619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients.
    Pham SM; Keenan RJ; Rao AS; Fontes PA; Kormos RL; Abu-Elmagd K; Zeevi A; Kawai A; Hattler BG; Hardesty RL
    Ann Thorac Surg; 1995 Oct; 60(4):1015-20. PubMed ID: 7574940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
    Li S; Salgar SK; Thanikachalam M; Murdock AD; Gammie JS; Demetris AJ; Zeevi A; Pham SM
    J Surg Res; 2006 Dec; 136(2):238-46. PubMed ID: 17046021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed xenogeneic chimerism (mouse+rat-->mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts.
    Li H; Ricordi C; Demetris AJ; Kaufman CL; Korbanic C; Hronakes ML; Ildstad ST
    Transplantation; 1994 Feb; 57(4):592-8. PubMed ID: 8116047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune status of recipients following bone marrow-augmented solid organ transplantation.
    Zeevi A; Pavlick M; Lombardozzi S; Banas R; Pappo O; Rao AS; Fontes P; Demetris J; Shapiro R; Dodson F
    Transplantation; 1995 Feb; 59(4):616-20. PubMed ID: 7878767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation without immunosuppression: future perspectives.
    Selvaggi G; Ricordi C; Bottino R; Tzakis AG
    Ital J Gastroenterol; 1996 May; 28(4):246-9. PubMed ID: 8842842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients.
    Wang M; Racine J; Zhang M; Wu T; Deng R; Johnston H; Shen C; Siswanto K; Zeng D
    J Immunol; 2014 Aug; 193(4):2005-15. PubMed ID: 25000982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher percentage of donor CD 34+ expression in peripheral blood of simultaneous pancreas/kidney/donor bone marrow versus than kidney/islet cell/donor bone marrow recipients.
    Burke GW; Ciancio G; Garcia-Morales R; Ricordi C; Alejandro R; Roth D; Tzakis A; Miller J
    Transplant Proc; 1998 Mar; 30(2):535-6. PubMed ID: 9532166
    [No Abstract]   [Full Text] [Related]  

  • 36. Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients: improved graft function and higher graft survival.
    Solgi G; Gadi V; Paul B; Mytilineos J; Pourmand G; Mehrsai A; Ranjbar M; Mohammadnia M; Nikbin B; Amirzargar AA
    Chimerism; 2013; 4(3):87-94. PubMed ID: 23639966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous administration of a low-dose mixture of donor bone marrow cells and splenocytes plus adenovirus containing the CTLA4Ig gene result in stable mixed chimerism and long-term survival of cardiac allograft in rats.
    Jin Y; Zhang Q; Hao J; Gao X; Guo Y; Xie S
    Immunology; 2003 Oct; 110(2):275-86. PubMed ID: 14511242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism.
    Graves SS; Hogan WJ; Kuhr C; Diaconescu R; Harkey M; Sale GE; Stone B; Georges GE; Storb R
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1201-8. PubMed ID: 18940673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.